References
- Moroni-ZentgrafPImpact of patient needs on design and usage of an inhalation device in respiratory medicineRespir Drug Deliv Eur20131141152
- VirchowJCCromptonGKDalNRImportance of inhaler devices in the management of airway diseaseRespir Med20081021101917923402
- LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
- OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
- MolimardMHow to achieve good compliance and adherence with inhalation therapyCurr Med Res Opin200521Suppl 4S33S3716138943
- RoyABattleKLurslurchachaiLHalmEAWisniveskyJPInhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthmaPrim Care Respir J201120214815421437565
- AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
- ShikiarRRentzAMSatisfaction with medication: an overview of conceptual, methodologic, and regulatory issuesValue Health20047220421515164810
- SmallMAndersonPVickersAKaySFermerSImportance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomesAdv Ther201128320221221331556
- ChrystynHSmallMMilliganGHigginsVGilEGEstruchJImpact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPDRespir Med2014108235836524209768
- KozmaCMSlatonTLMonzBUHodderRReesePRDevelopment and validation of a patient satisfaction and preference questionnaire for inhalation devicesTreat Respir Med200541415215725049
- Spiriva Respimat 25 microgram, inhalation solution (summary of product characteristics)Ingelheim, GermanyBoehringer Ingelheim2015
- Hirobriz®/Onbrez®/Oslif® Breezhaler® (summary of product characteristics)Basel, SwitzerlandNovartis2014
- AndersonPJPatient preferences for and satisfaction with inhaler devicesEur Respir Rev20051496109116
- BlasiFRaddiFMiravitllesMInteractive Monitoring Service and COPD: is it possible to reduce nonadherence?COPD201512322723225093542
- CicilianiAMLangguthPBickmanDWachtelHVoshaarTIn vitro dose comparison of Respimat® Soft Mist™ inhaler with dry powder inhalers for COPD maintenance therapyAbstract presented at: International Society of Addiction Medicine Annual CongressApril 6–10, 2013Chapel Hill, NC
- HodderRDesign and interpretation of device preference trials: marketing tools or scientific instruments?Respir Drug Deliv200611936
- SchurmannWSchmidtmannSMoroniPMasseyDQidanMRespimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfactionTreat Respir Med200541536115725050
- HodderRReesePRSlatonTAsthma patients prefer Respimat Soft Mist Inhaler to TurbuhalerInt J Chron Obstruct Pulmon Dis2009422523219554196
- FreytagFRau-BergerHGlaabTRespimat Soft Mist Inhaler preferred to Diskus by patients with COPD and/or asthmaAm J Respir Crit Care Med2007175A639
- FergusonGTGhafouriMDaiLDunnLJCOPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled studyInt J Chron Obstruct Pulmon Dis2013813915023658479